Skip to main content
Log in

Participant views on consent in cancer genetics research: preparing for the precision medicine era

  • Original Article
  • Published:
Journal of Community Genetics Aims and scope Submit manuscript

Abstract

The Precision Medicine Initiative (PMI) has created considerable discussions about research participant issues including re-consent and how and when to incorporate the patient experience into clinical trials. Within the changing landscape of genetic and genomic research, the preferences of participants are lacking yet are needed to inform policy. With the growing use of biobanks intended to support studies, including the national research cohort proposed under the PMI, understanding participant preferences, including re-consent, is a pressing concern. The Participant Issues Project (PIP) addresses this gap, and here we present data on participant attitudes regarding re-consent and broad consent in research studies. PIP study participants came from the Northwest Cancer Genetics Registry and included cancer patients, relatives, and controls. Thirty telephone interviews were conducted and analyzed using content and thematic analysis. Results indicate that in some scenarios, re-consent is needed. Most participants agreed that re-consent was necessary when the study direction changed significantly or a child participant became an adult, but not if the genetic variant changed. Most participants’ willingness to participate in research would not be affected if the researcher or institution profited or if a broad consent form were used. Participants emphasized re-consent to provide information and control of the use of their data, now relevant for tailored treatment, while also prioritizing research as important. In the era of precision medicine, it is essential that policy makers consider participant preferences with regard to use of their materials and that participants understand genetic and genomic research and its harms and benefits as well as what broad consent entails, including privacy and re-identification risks.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Alyass A, Turcotte M, Meyre D (2015) From big data analysis to personalized medicine for all: challenges and opportunities. BMC Med Genomics 8:33

    Article  PubMed  PubMed Central  Google Scholar 

  • Annas GJ (2001) Reforming informed consent to genetic research. JAMA 286(18):2326–2328

    Article  CAS  PubMed  Google Scholar 

  • Anton-Culver H, Ziogas A, Bowen D et al (2003) The Cancer Genetics Network: recruitment results and pilot studies. Community Genet 6(3):171–177

    Article  PubMed  Google Scholar 

  • Arnason V (2004) Coding and consent: moral challenges of the database project in Iceland. Bioethics 18:27–49

    Article  PubMed  Google Scholar 

  • Bathe OF, McGuire AL (2009) The ethical use of existing samples for genome research. Genet Med 11(10):712–715

    Article  PubMed  Google Scholar 

  • Bledsoe MJ, Grizzle WE, Clark BJ, Zeps N (2012) Practical implementation issues and challenges for biobanks in the return of individual research results. Genet Med 14(4):478–483

    Article  PubMed  PubMed Central  Google Scholar 

  • Caulfield T (2007) Biobanks and blanket consent: the proper place of the public good and public perception rationales. King Law J 18:209–226

    Google Scholar 

  • Colditz GA (2009) Constraints on data sharing: experience from the nurses' health study. Epidemiology 20(2):169–171

    Article  PubMed  PubMed Central  Google Scholar 

  • Edwards KL, Lemke AA, Trinidad SB et al (2011) Attitudes toward genetic research review: results from a survey of human genetics researchers. Public Health Genomics 14(6):337–345

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Edwards KL, Lemke AA, Trinidad SB et al (2012) Genetics researchers' and IRB professionals' attitudes toward genetic research review: a comparative analysis. Genet Med 14(2):236–242

    Article  PubMed  PubMed Central  Google Scholar 

  • El Emam K, Jonker E, Arbuckle L, Malin B (2011) A systematic review of re-identification attacks on health data. PLoS One 6(12), e28071

    Article  PubMed  PubMed Central  Google Scholar 

  • Ewing AT, Bollinger E, Tetteyfio E et al (2015) Demographic differences in willingness to provide broad and narrow consent for biobank research. Biopreserv Biobank 13:98–106

    Article  PubMed  PubMed Central  Google Scholar 

  • Forsberg JS, Hansson MG, Eriksson S (2011) The risks and benefits of re-consent. Science 332(6027):306

    Article  PubMed  Google Scholar 

  • Graneheim UH, Lundman B (2004) Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today 24(2):105–112

    Article  CAS  PubMed  Google Scholar 

  • Gurwitz D, Fortier I, Lunshof JE, Knoppers BM (2009) Research ethics. Children and population biobanks. Science 325(5942):818–819

    Article  PubMed  Google Scholar 

  • Gymrek M, McGuire AL, Golan D, Halperin E, Erlich Y (2013) Identifying personal genomes by surname inference. Science 339(6117):321–324

    Article  CAS  PubMed  Google Scholar 

  • Haga SB, Beskow LM (2008) Ethical, legal, and social implications of biobanks for genetic research. Adv Genet 60:505–544

    Article  PubMed  Google Scholar 

  • Hawgood S, Hook-Barnard IG, O’Brien TC, Yamamoto KR (2015) Precision medicine: beyond the inflection point. Sci Transl Med 7:300.PS17

    Article  Google Scholar 

  • Helgesson G (2012) In defense of broad consent. Camb Q Healthc Ethics 21(1):40–50

    Article  PubMed  Google Scholar 

  • Henderson G, Garrett J, Bussey-Jones J, Moloney ME, Blumenthal C, Corbie-Smith G (2008) Great expectations: views of genetic research participants regarding current and future genetic studies. Genet Med 10(3):193–200

    Article  PubMed  Google Scholar 

  • Hofmann B (2009) Broadening consent - and diluting ethics? J Med Ethics 35:125–129

    Article  CAS  PubMed  Google Scholar 

  • Ioannidis JP (2013) Informed consent, big data, and the oxymoron of research that is not research. Am J Bioeth 13(4):40–42

    Article  PubMed  Google Scholar 

  • Kelly SE, Spector TD, Cherkas LF et al (2015) Evaluating the consent preferences of UK research volunteers for genetic and clinical studies. PLoS ONE 10:e0118027

    Article  PubMed  PubMed Central  Google Scholar 

  • Knoppers BM, Lévesque E (2011) Introduction: return of research results: how should research results be handled? J Law Med Ethics 39(4):574–576

    Article  PubMed  Google Scholar 

  • Lemke AA, Trinidad SB, Edwards KL, Starks H, Wiesner GL (2010) Attitudes toward genetic research review: results from a national survey of professionals involved in human subjects protection. J Empir Res Hum Res Ethics 5(1):83–91

    Article  PubMed  PubMed Central  Google Scholar 

  • Lunshof JE, Chadwick R, Vorhaus DB, Church GM (2008) From genetic privacy to open consent. Nat Rev Genet 9(5):406–411

    Article  CAS  PubMed  Google Scholar 

  • McGuire AL, Hamilton JA, Lunstroth R, McCullough LB, Goldman A (2008) DNA data sharing: research participants' perspectives. Genet Med 10(1):46–53

    Article  PubMed  PubMed Central  Google Scholar 

  • Novick G (2008) Is there a bias against telephone interviews in qualitative research? Res Nurs Health 31(4):391–398

    Article  PubMed  PubMed Central  Google Scholar 

  • Overby CA, Tarczy-Hornoch (2013) Personalized medicine: challenges and opportunities for translational bioinformatics. Per Med 10:453–462

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petrini C (2010) "Broad" consent, exceptions to consent and the question of using biological samples for research purposes different from the initial collection purpose. Soc Sci Med 70:217–220

    Article  PubMed  Google Scholar 

  • Platt J, Bollinger J, Dvoskin R et al (2014) Public preferences regarding informed concent models for participation in population-based genomic research. Genet Med 16:11–18

    Article  PubMed  PubMed Central  Google Scholar 

  • Sheehan M (2011) Can broad consent be informed consent? Public Health Ethics 4(3):226–235

    Article  PubMed  PubMed Central  Google Scholar 

  • Simon C, Shinkunas LA, Brandt D, Williams JK (2012) Individual genetic and genomic research results and the tradition of informed consent: exploring US review board guidance. J Med Ethics 38(7):417–422

    Article  PubMed  PubMed Central  Google Scholar 

  • Steinsbekk KS, Ursin LO, Skolbekken JA, Solberg B (2013) We're not in it for the money-lay people's moral intuitions on commercial use of 'their' biobank. Med Health Care Philos 16(2):151–162

    Article  PubMed  PubMed Central  Google Scholar 

  • Tasse AM, Budin-Ljosne I, Knoppers BM, Harris JR (2010) Retrospective access to data: the ENGAGE consent experience. Eur J Hum Genet 18(7):741–745

    Article  PubMed  PubMed Central  Google Scholar 

  • Trinidad SB, Fullerton SM, Bares JM, Jarvik GP, Larson EB, Burke W (2010) Genomic research and wide data sharing: views of prospective participants. Genet Med 12(8):486–495

    Article  PubMed  PubMed Central  Google Scholar 

  • Trinidad SB, Fullerton SM, Ludman EJ, Jarvik GP, Larson EB, Burke W (2011) Research practice and participant preferences: the growing gulf. Science 331(6015):287–288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vaismoradi M, Turunen H, Bondas T (2013) Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci 15(3):398–405

    Article  PubMed  Google Scholar 

  • Willison DJ, Schwartz L, Abelson J et al (2007) Alternatives to project-specific consent for access to personal information for health research: what is the opinion of the Canadian public? J Am Med Inform Assoc 14(6):706–712

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study involved multiple collaborators, including our valued colleagues enrolled in the Northwest Cancer Genetics Registry for their ongoing participation in and contribution to cancer research; the University of Washington (UW) Department of Epidemiology, the Institute for Public Health Genetics, and the Department of Biomedical Informatics and Medical Education; Boston University, Department of Community Health Sciences; University of Georgia, Department of Communication Studies; Johns Hopkins University, Genetics and Public Policy Center; the National Coalition for Health Professional Education in Genetics; and the University of California, Irvine. The authors also wish to also acknowledge and thank Nirupama Schridhar, Katherine W. Snapinn, Joan Scott, and David Kaufmann for their work contributing to the earlier stages of this project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karen L. Edwards.

Ethics declarations

This study was funded by the National Cancer Institute (grant 1R01CA149051-01A1; KL Edwards, PI.)

Conflict of interest

The authors declare no conflicts of interest.

Ethical approval

All procedures performed were in accordance with the ethical standards of the institutional research boards and with the 1964 Helsinki declaration and its later amendments.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Edwards, K.L., Korngiebel, D.M., Pfeifer, L. et al. Participant views on consent in cancer genetics research: preparing for the precision medicine era. J Community Genet 7, 133–143 (2016). https://doi.org/10.1007/s12687-015-0259-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12687-015-0259-8

Keywords

Navigation